Prospective Comparison of Risk Factors and Demographic and Clinical Characteristics of Community-acquired, Methicillin-resistant Versus Methicillin-susceptible Staphylococcus Aureus Infection in Children
Overview
Affiliations
Context: Community-acquired, methicillin-resistant (CA-MRSA) infections in children are increasing in frequency for unknown reasons.
Objectives: To compare the presence of risk factors for methicillin resistance between patients with CA-MRSA and community-acquired methicillin-susceptible (CA-MSSA) infection and to compare the presence of risk factors among household contacts of the patients from both groups. To compare the demographic and clinical characteristics between children with CA-MRSA and CA-MSSA infection.
Design: Prospective observational study conducted between February 2, 2000 and November 14, 2000, excluding the month of May and the period between September 2 and October 15.
Setting And Patients: Texas Children's Hospital, Houston, TX; inpatients and outpatients with community-acquired infection.
Main Outcome Measures: Proportion of MRSA among all community-acquired infections. The presence of risk factors associated with methicillin resistance among patients, and their household contacts, with CA-MRSA and CA-MSSA.
Results: The monthly rates of methicillin resistance of varied between 35 and 51%. CA-MSSA isolates were associated with deep-seated infections significantly more often (30%) than CA-MRSA isolates (11%; P= 0.01). CA-MRSA isolates were generally susceptible to clindamycin and trimethoprim-sulfamethoxazole and resistant to erythromycin. There were no significant differences in the exposure to risk factors between children with CA-MRSA and CA-MSSA infection. No significant risk factors for CA-MRSA were identified among household contacts.
Conclusions: MRSA is an established, community-acquired pathogen in our area. This necessitates a change in empiric therapy of infections suspected to be caused by.
[Prevalence and risk factors for methicillin-resistant Staphylococcus aureus infection in children].
Marin Olivan P, Ferrando Monleon S, Breton-Martinez J, Piolatti Luna A, Hernandez Monleon I, Fuertes Latasa C Rev Esp Quimioter. 2024; 37(2):170-175.
PMID: 38245868 PMC: 10945100. DOI: 10.37201/req/113.2023.
Antibiotic persistence and its impact on the environment.
Gangar T, Patra S 3 Biotech. 2023; 13(12):401.
PMID: 37982084 PMC: 10654327. DOI: 10.1007/s13205-023-03806-6.
Zaher H, El Baz S, Alothaim A, Alsalamah S, Alghonaim M, Alawam A Antibiotics (Basel). 2023; 12(2).
PMID: 36830115 PMC: 9952529. DOI: 10.3390/antibiotics12020205.
Ali F, Immergluck L, Leong T, Waller L, Malhotra K, Jerris R EGEMS (Wash DC). 2019; 7(1):50.
PMID: 31565665 PMC: 6743030. DOI: 10.5334/egems.308.
Jackson K, Gokhale R, Nadle J, Ray S, Dumyati G, Schaffner W Clin Infect Dis. 2019; 70(6):1021-1028.
PMID: 31245810 PMC: 7902232. DOI: 10.1093/cid/ciz323.